Angle Share News (AGL)

Angle posts positive prostate cancer treatment tests update

Medical diagnostic company Angle said the investigation into the clinical use of its Parsortix system in prostate cancer treatments was encouraging. Researchers from Barts Cancer Institute, which is carrying out the tests, were able to successfully harvest circulating tumor cells from all the 52 ass

ANGLE Says Prostate Cancer Study Results With Parsortix "Encouraging"

ANGLE Gets Chinese And Australian Patents For Parsotix

LONDON MIDDAY BRIEFING: Sky, ARM Hit Highs After Strong Results

ANGLE Gets Positive Results For Parsotix In Ovarian Cancer Detection

ANGLE's Parsortix System Successfully Tested, Results Published

ANGLE Raises Further GBP1.5 Million In Share Subscription (ALLISS)

UK MIDDAY BRIEFING: "Time And Money Are Running Out For Greece"

UK WINNERS & LOSERS: Hunting Slides After Warning On Low Oil Price

ANGLE Falls On Discounted Placing; Signs Collaboration Deal (ALLISS)

ANGLE Posts Widened First-Half Loss On Parsortix Investment

UK MIDDAY BRIEFING: EasyJet, IAG Flying High

UK WINNERS & LOSERS: Afren Plunges On Funding Issues

ANGLE Says Patient Data Backs Parsortix Use To Detect Ovarian Cancer

UK MORNING BRIEFING: Shares Up, Pound Below USD1.50 After ECB Move